Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


30.05.2022

1 Blood
2 Bone Marrow Transplant
1 Br J Haematol
1 Haematologica
1 Leuk Lymphoma


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. HAMNVAG HM, Velankar M
    Hemophagocytic lymphohistiocytosis with multiple possible etiologies including rare primary bone marrow lymphoma.
    Blood. 2022;139:3226.
    PubMed        


    Bone Marrow Transplant

  2. FERNANDEZ-SOJO J, Cid J, Azqueta C, Valdivia E, et al
    Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01722.
    PubMed        

  3. ANGELOV D, Dillon J, Mellerick L, Pender E, et al
    Allogeneic transplantation in Cutaneous T-cell Lymphoma: improved outcomes associated with early transplantation and acute graft versus host disease.
    Bone Marrow Transplant. 2022 May 20. pii: 10.1038/s41409-022-01713.
    PubMed        


    Br J Haematol

  4. SHICHIJO T, Nosaka K, Tatetsu H, Higuchi Y, et al
    Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.
    Br J Haematol. 2022 May 24. doi: 10.1111/bjh.18281.
    PubMed         Abstract available


    Haematologica

  5. MADUGULA KK, Joseph J, DeMarino C, Ginwala R, et al
    Regulation of Human T-cell Leukemia Virus type 1 antisense promoter by Myocyte Enhancer Factor-2C in the context of Adult T-cell leukemia and lymphoma.
    Haematologica. 2022 May 26. doi: 10.3324/haematol.2021.279542.
    PubMed         Abstract available


    Leuk Lymphoma

  6. MAN J, Wang H, Qian X, Chen L, et al
    TCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study.
    Leuk Lymphoma. 2022 May 26:1-8. doi: 10.1080/10428194.2022.2076852.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: